Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed".
Saved in:
| Title: | Reply to: "Is the TAE score a promising prognostic predictor for unresectable hepatocellular carcinoma treated with TACE plus lenvatinib with PD‑1 inhibitors? Further validation should be performed". |
|---|---|
| Authors: | Zeng ZX; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China., Wu JY; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Dongjie Road 134, Fuzhou, 350001, Fujian Province, China., Zhuang SW; Department of Interventional Radiology, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, Fujian Province, China., Yan ML; Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China. yanmaolin74@163.com.; Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital, Dongjie Road 134, Fuzhou, 350001, Fujian Province, China. yanmaolin74@163.com. |
| Source: | Hepatology international [Hepatol Int] 2024 Oct; Vol. 18 (5), pp. 1589-1590. Date of Electronic Publication: 2024 Jul 08. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1936-0541 (Electronic) Linking ISSN: 19360533 NLM ISO Abbreviation: Hepatol Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1936-0541 |
|---|---|
| DOI: | 10.1007/s12072-024-10682-6 |
